SEC Form 4 · accession 0001140361-16-056149
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Robert Ajer
Officer — SVP, Chief Commercial Officer
Period of report
Feb 29, 2016
Accepted (ET)
Mar 2, 2016 · 8:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 29, 2016 | F | 17,656 | $81.87 | D | 50,532 | D |
Table II — derivative securities
No Table II lines on this filing.